...Previous studies have revealed disparities in COVID-19-related deaths among population demographics, including age, race and pre-existing medical conditions, but a new study by the University of Minnesota School of Public Health (SPH) has determined another factor – a person’s profession.
A new investigation led by researchers from the University College London and Dartmouth College suggests 14% of Americans had long COVID by the end of 2022. The details of the investigation are published in PLOS One.
Moreover, Americans who report having experienced long COVID said they also experienced more anxiety, low mood, and difficulty with memory. ...
A study based on 211 pregnant women given the antiviral drug nirmatrelvir and ritonavir (Paxlovid) during pregnancy for acute COVID-19 infections shows no increased risk of adverse events in the women or their babies and a reduced risk of complications called the maternal morbidity and mortality index (MMMI).
The findings, published today in Nature Medicine, suggest the drug is safe to use in pregnancy and is effective in reducing MMMI risk but not COVID-related hospitalizations.
COVID-19 activity in the United States last week showed more signs of declines, though deaths were up, and the World Health Organization's (WHO's) monthly snapshot of global activity suggests decreased activity, though the group cautioned that few countries are reporting data.
